Enveric Biosciences Stock (NASDAQ: ENVB) stock price, news, charts, stock research, profile.
You can purchase shares of Enveric Biosciences (NASDAQ:ENVB) through any online brokerage.
Other companies in Enveric Biosciences’s space includes: Biofrontera (NASDAQ:BFRI), NovaBay Pharmaceuticals (AMEX:NBY), Processa Pharma (NASDAQ:PCSA), Titan Pharma (NASDAQ:TTNP) and cbdMD (AMEX:YCBD).
Enveric Biosciences has a consensus price target of $3.82.
The stock price for Enveric Biosciences (NASDAQ: ENVB) is $0.3727 last updated November 19, 2024 at 5:36 PM EST.
There are no upcoming dividends for Enveric Biosciences.
Enveric Biosciences’s Q3 earnings are confirmed for Thursday, November 14, 2024.
There is no upcoming split for Enveric Biosciences.
Enveric Biosciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.